We arrange several open investor events with our covered companies each year. Please subscribe to get information about our upcoming Introduce events. 

Sign up >

Press the button and be introduced to a new random company!

Introduce me >


New company at Introduce - Nanexa

08:20 / 16 april 2021 Article

Today ABG Sundal Collier sponsored research initiates coverage of Nanexa. Read the full report here!

Nanexa - adding another layer to drug development


Nanexa is a Swedish drug-delivery company listed on Nasdaq First North Growth Market, leveraging its proprietary drug formulation PharmaShell to convert short-acting injectables into long-acting, sustained release versions with enhanced properties. The company is pursuing both technology licensing and internal generic drug development for subsequent product licensing or independent commercialisation.